Diagnósticos da América S.A. (DASA3.SA)
- Previous Close
1.7800 - Open
0.0000 - Bid 1.7900 x --
- Ask 1.8000 x --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 5.2900 - Volume
0 - Avg. Volume
771,722 - Market Cap (intraday)
2.249B - Beta (5Y Monthly) 0.60
- PE Ratio (TTM)
-- - EPS (TTM)
-0.9600 - Earnings Date May 13, 2025 - May 19, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 27, 2022
- 1y Target Est
4.26
Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. It operates through Hospitals and Oncology; Diagnostics and Care Coordination; and Diagnostics International Operations segments. The company offers outpatient doctors; medical and outpatient services; diagnostic support assistants for private patients or partner companies; care coordination, remote monitoring, population health management, home medical, and paramedical services; and medical consultations. It is also involved in the development and licensing of computer programs and predictive models using information technology and data science; and brokerage activities. In addition, the company provides oncology, hematology, and infusion centers. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 2000. Diagnósticos da América S.A. was founded in 1961 and is headquartered in Barueri, Brazil.
www.dasa3.com.br--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: DASA3.SA
View MorePerformance Overview: DASA3.SA
Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is IBOVESPA (^BVSP) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DASA3.SA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DASA3.SA
View MoreValuation Measures
Market Cap
2.25B
Enterprise Value
13.35B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.15
Price/Book (mrq)
0.28
Enterprise Value/Revenue
0.87
Enterprise Value/EBITDA
6.71
Financial Highlights
Profitability and Income Statement
Profit Margin
-7.82%
Return on Assets (ttm)
2.60%
Return on Equity (ttm)
-15.64%
Revenue (ttm)
15.32B
Net Income Avi to Common (ttm)
-1.2B
Diluted EPS (ttm)
-0.9600
Balance Sheet and Cash Flow
Total Cash (mrq)
1.83B
Total Debt/Equity (mrq)
167.83%
Levered Free Cash Flow (ttm)
-251.28M